Medical Examination and Clinical Diagnosis

Application research of PGT in blocking the inheritance of novel mutations in the PKHD1 gene in autosomal recessive polycystic kidney disease pedigrees

  • Ning WANG ,
  • Yan HAO ,
  • Dawei CHEN ,
  • Zhiguo ZHANG ,
  • Dan KUANG ,
  • Qing ZHANG ,
  • Yiqi YING ,
  • Zhaolian WEI ,
  • Ping ZHOU ,
  • Yunxia CAO
Expand
  • 1.Department of Obstetrics and Gynecology,the First Affiliated Hospital of Anhui Medical University,Hefei 230000,China
    2.Key Laboratory of Study on Abnormal Gametes and Reproductive Tract,National Health Commission,Hefei 230000,China
    3.Key Laboratory of Population Health Across Life Cycle,Ministry of Education of the People′s Republic of China,Hefei 230000,China

Received date: 2023-10-30

  Online published: 2024-04-08

Abstract

Objective To investigate the application value of single nucleotide polymorphism (SNP) linkage analysis based on next-generation sequencing (NGS) technology in preimplantation genetic testing (PGT) of families with autosomal recessive polycystic kidney disease (ARPKD). Methods A family with ARPKD was selected, where the female member had a pregnancy ultrasound revealing polycystic kidney in the fetus. Genetic testing showed compound heterozygous mutations of the polycystic kidney/polycystic liver disease 1 gene (PKHD1), c.10444C > T (paternal) and c.4303del (maternal), with the c.4303del mutation being reported for the first time. Targeting the coding region of the PKHD1 gene, 335 high-density tightly linked SNP sites were selected in the upstream and downstream 2M regions using multiplex polymerase chain reaction (PCR) and NGS. The couple's SNP risk haplotypes carrying gene mutations were constructed. After in vitro fertilization, blastocyst culture was performed. Trophoblastic cells obtained from the biopsy were subjected to whole-genome amplification, and NGS was used for linkage analysis and low-depth chromosomal aneuploidy screening of the embryos. Sanger sequencing was used to verify the results of embryo linkage analysis. Results Among the 6 biopsied embryos, 4 were mutation-free and euploid, 1 exhibited heterozygous for the mutation and mosaic while another unstable sequencing data, making it impossible to judge. One of the mutation-free and developmentally healthy euploid embryos was implanted into the maternal uterus, resulting in the full-term delivery of a healthy baby. Conclusion Application of NGS-based SNP linkage analysis in PGT can effectively blocking the vertical transmission of ARPKD within families, while avoiding abortion issues caused by aneuploid embryos. This study is also the first PGT report targeting the PKHD1 gene c.4303del mutation.

Cite this article

Ning WANG , Yan HAO , Dawei CHEN , Zhiguo ZHANG , Dan KUANG , Qing ZHANG , Yiqi YING , Zhaolian WEI , Ping ZHOU , Yunxia CAO . Application research of PGT in blocking the inheritance of novel mutations in the PKHD1 gene in autosomal recessive polycystic kidney disease pedigrees[J]. The Journal of Practical Medicine, 2024 , 40(7) : 1006 -1010 . DOI: 10.3969/j.issn.1006-5725.2024.07.022

References

1 SIEBEN C J, HARRIS P C. Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing[J]. Kidney360, 2023, 4(8): 1155-1173. doi:10.34067/kid.0000000000000209
2 LU H, GALEANO M C R, OTT E, et al. Mutations in DZIP1 L,which encodes a ciliary-transition-zone protein,cause autosomal recessive polycystic kidney disease[J]. Nat Genet, 2017, 49(7): 1025-1034. doi:10.1038/ng.3871
3 中华医学会医学遗传学分会遗传病临床实践指南撰写组. Leber遗传性视神经病变的临床实践指南[J]. 中华医学遗传学杂志, 2020, 37(3): 284-288. doi:10.3760/cma.j.issn.1003-9406.2020.03.010
4 卢晓梅,霍本刚,黄楠,等. 透析血流量对老年维持性血液透析患者预后的影响[J]. 实用医学杂志, 2023, 39(10): 1269-1273. doi:10.3969/j.issn.1006-5725.2023.10.014
5 BERGMANN C, GUAYWOODFORD L M, HARRIS P C, et al. Polycystic kidney disease[J]. Nat Rev Dis Primers, 2018, 4(1):50. doi:10.1038/s41572-018-0047-y
6 CORDIDO A, VIZOSOGONZALEZ M, GARCIAGONZALEZ M A. Molecular Pathophysiology of Autosomal Recessive Polycystic Kidney Disease[J]. Int J Mol Sci, 2021, 22(12): 6523. doi:10.3390/ijms22126523
7 DELL K M. The spectrum of polycystic kidney disease in children[J]. Adv Chronic Kidney Dis, 2011, 18(5):339-347. doi:10.1053/j.ackd.2011.05.001
8 CHENGBING W, JIA L, KENICHI T,et al. Centrosomal protein dzip1l binds cby,promotes ciliary bud formation,and acts redundantly with Bromi to regulate ciliogenesis in the mouse[J]. Development, 2018, 145: 164236. doi:10.1242/dev.164236
9 PARASKEVI G, TAYLOR R. The genetics of Autosomal Recessive Polycystic Kidney Disease (ARPKD)[J]. Biochim Biophys Acta Mol Basis Dis, 2022, 1868(4): 166348. doi:10.1016/j.bbadis.2022.166348
10 BERGMANN C, SENDEREK J, WINDELEN E, et al. Clinical consequences of PKHD1 mutations in 164 patients with autosomal-recessive polycystic kidney disease(ARPKD)[J]. Kidney Int, 2005, 67(3): 829-848. doi:10.1111/j.1523-1755.2005.00148.x
11 BURGMAIER K, BRINKER L, ERGER F, et al. Refining genotype-phenotype correlations in 304 patients with autosomal recessive polycystic kidney disease and PKHD1 gene variants[J]. Kidney Int, 2021, 100(3): 650-659.
12 赵延凤,黄宇戈. 婴儿型多囊肾1例临床表型与基因型分析[J]. 临床儿科志, 2018, 36(6): 420-423.
13 何天文,卢建,陈创奇,等. 基于二代测序技术的常染色体隐性遗传性多囊肾病家系胚胎植入前遗传学分析[J]. 检验医学, 2022, 37(3): 257-263. doi:10.3969/j.issn.1673-8640.2022.03.014
14 ERGER F, BRüCHLE N O, GEMBRUCH U, et al. Prenatal ultrasound, genotype, and outcome in a large cohort of prenatally affected patients with autosomal-recessive polycystic kidney disease and other hereditary cystic kidney diseases[J]. Arch Gynecol Obstet, 2017, 295(4): 897-906. doi:10.1007/s00404-017-4336-6
15 SIMONINI C, FR?SCHEN E M, NADAL J, et al. Prenatal ultrasound in fetuses with polycystic kidney appearance-expanding the diagnostic algorithm[J]. Arch Gynecol Obstet, 2023, 308: 1287-1300. doi:10.1007/s00404-022-06814-8
16 陈大蔚,章志国,郝燕,等. 成骨发育不全家系遗传学分析及植入前遗传学诊断研究[J]. 中国实用妇科与产科杂志, 2018, 34(4): 433-438.
17 QIN M, ZHU X, ZHANG Z, et al. Genetic analysis and preimplantation genetic diagnosis of Chinese Marfan syndrome patients[J]. J Genet Genomics, 2019, 46(6): 319-323. doi:10.1016/j.jgg.2019.04.003
18 YEAGER S, MEHTA S, SODHI M, et al. Can preimplantation genetic diagnosis be used for monogenic endocrine diseases[J]? J Pediatr Endocrinol Metab, 2019, 32(12): 1305-1310. doi:10.1515/jpem-2019-0184
19 DE R M, BERCKMOES V. Preimplantation Genetic Testing for Monogenic Disorders[J]. Genes(Basel), 2020, 11(8): 871. doi:10.3390/genes11080871
20 CHEN D, XU Y, DING C, et al. The inconsistency between two major aneuploidy-screening platforms-single-nucleotide polymorphism array and next-generation sequencing-in the detection of embryo mosaicism[J]. BMC Genomics, 2022, 23(1): 62. doi:10.1186/s12864-022-08294-1
21 DOROFTEI B, ILIE O D, ANTON N, et al. A Mini-Review Regarding the Clinical Outcomes of In Vitro Fertilization (IVF) Following Pre-Implantation Genetic Testing (PGT)-Next Generation Sequencing (NGS) Approach[J]. Diagnostics, 2022, 12(8): 1911. doi:10.3390/diagnostics12081911
22 ESMAEILI F, NARIMANI Z, VASIGHI M. Discovering SNP-disease relationships in genome-wide SNP data using an improved harmony search based on SNP locus and genetic inheritance patterns[J]. PLoS One, 2023, 18(10): e0292266. doi:10.1371/journal.pone.0292266
23 HYMAN L B, CHRISTOPHER C R, ROMERO P A. Competitive SNP-LAMP probes for rapid and robust single-nucleotide polymorphism detection[J]. Cell Rep Methods, 2022, 2(7): 100242. doi:10.1016/j.crmeth.2022.100242
24 GRECO E, LITWICKA K, MINASI M G, et al. Preimplantation Genetic Testing: Where We Are Today[J]. Int J Mol Sci, 2020, 21(12): 4381. doi:10.3390/ijms21124381
25 CECHOVA M, MIGA K H. Comprehensive variant discovery in the era of complete human reference genomes[J]. Nat Methods, 2023, 20(1): 17-19. doi:10.1038/s41592-022-01740-8
Outlines

/